Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9109245 Cell compositions derived from dedifferentiated reprogrammed cells

Overview Structured Data Issues Contributors Activity

All edits

Edits on 23 Oct, 2024

"update inverses"

edited on 23 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12123023 Methods for generating stem cell-derived β cells and methods of use thereof

0

Edits on 7 Aug, 2024

"update inverses"

edited on 7 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

0

Edits on 31 Jul, 2024

"update inverses"

edited on 31 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

0

Edits on 6 Jun, 2024

"update inverses"

edited on 6 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11999971 Stem cell derived islet differentiation

0

Edits on 4 Apr, 2024

"update inverses"

edited on 4 Apr, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11945795 Islet cell manufacturing compositions and methods of use

0

Edits on 22 Feb, 2024

"update inverses"

edited on 22 Feb, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11905530 Cell encapsulation device comprising a pancreatic progenitor cell population

0

"update inverses"

edited on 22 Feb, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11904001 Universal donor cells and related methods

0

Edits on 3 Dec, 2023

"Add patent abstract"

edited on 3 Dec, 2023

Edits made to:

Article (+300 characters)

Article

Patent abstract

Disclosed herein are cell culture compositions, for example, pancreatic cell culture compositions, derived from dedifferentiated human reprogrammed pluripotent stem cells, such as induced pluripotent stem (iPS) cells, and methods for producing and using such cell culture compositions.

Edits on 16 Jul, 2023

"Remove leading 0 from patent number"

edited on 16 Jul, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 09109245 Cell compositions derived from dedifferentiated reprogrammed cells US Patent 9109245 Cell compositions derived from dedifferentiated reprogrammed cells

Infobox

Patent Number

091092450

Patent Number

91092450

Edits on 24 May, 2023

"Remove website redirecting to Patent Public Search front page"

edited on 24 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=091092450

Edits on 23 Apr, 2023

"Entity importer update"

edited on 23 Apr, 2023

Infobox

Is a

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

091092450

Date of Patent

August 18, 2015

0

Patent Application Number

137610780

Date Filed

February 6, 2013

0

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=091092450

Patent Primary Examiner

Lora E Barnhart Driscoll

0

Edits on 8 Jun, 2022

"Entity importer update"

edited on 8 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=09109245

Edits on 2 Jan, 2022

"Created via: Entity Importer"

created this topic on 2 Jan, 2022

Edits made to:

Infobox (+7 properties)

‌

US Patent 09109245 Cell compositions derived from dedifferentiated reprogrammed cells

Infobox

Is a

Patent jurisdiction

United States Patent and Trademark Office

Patent number

09109245

Date of patent

August 18, 2015

Patent application number

13761078

Date Filed

February 6, 2013

Patent primary examiner

Lora E Barnhart Driscoll

Find more entities like US Patent 9109245 Cell compositions derived from dedifferentiated reprogrammed cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool